Your browser doesn't support javascript.
loading
Toward the development of a protein-based group B Streptococcus vaccine.
Dominguez, Kristen; Randis, Tara M.
Affiliation
  • Dominguez K; Department of Molecular Medicine, University of South Florida; Morsani School of Medicine.
  • Randis TM; Department of Molecular Medicine, University of South Florida; Morsani School of Medicine.
Cell Rep Med ; 3(2): 100536, 2022 02 15.
Article in En | MEDLINE | ID: mdl-35243427
ABSTRACT
Clinical trials of protein-based vaccines to prevent Group B streptococcal infections are underway. In this issue of Cell Reports Medicine, Pawlowski et al.1 provide an extensive characterization of the immune response generated by the recently tested GBS-NN vaccine.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Streptococcal Vaccines Limits: Humans Language: En Journal: Cell Rep Med Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Streptococcal Vaccines Limits: Humans Language: En Journal: Cell Rep Med Year: 2022 Document type: Article